Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose randomized PK and safety study of Captisol-enabled budesonide inhalation versus Pulmicort Respules in children with asthma
2006-004035-30Phase 2Completed
- Sponsor
- Verus Pharmaceuticals
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of budesonide in asthma (2 arms), sponsored by Verus Pharmaceuticals. Primary endpoints: Safety and Tolerability. Started Sep 2006; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-004035-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004035-30.